Gene · 7314
Papers1,451
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,451
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive analysis of mitophagy-related genes in NSCLC diagnosis and immune scenery: based on bulk and single-cell RNA sequencing data. | Front Immunol | 2023 | 38155968 | PubTator, text mining | PubMed |
| Adaptive changes in the DNA damage response during skeletal muscle cell differentiation. | Front Cell Dev Biol | 2023 | 38089884 | PubTator, text mining | PubMed |
| Constructing a T-Cell Receptor-Related Gene Signature for Prognostic Stratification and Therapeutic Guidance in Head and Neck Squamous Cell Carcinoma. | Cancers (Basel) | 2023 | 38067199 | PubTator, text mining | PubMed |
| Interaction dynamics between innate and adaptive immune cells responding to SARS-CoV-2 vaccination in non-human primates. | Nat Commun | 2023 | 38042809 | PubTator, text mining | PubMed |
| Personalized tumor combination therapy optimization using the single-cell transcriptome. | Genome Med | 2023 | 38041202 | PubTator, text mining | PubMed |
| Mitophagy genes in ovarian cancer: a comprehensive analysis for improved immunotherapy. | Discov Oncol | 2023 | 38038814 | PubTator, text mining | PubMed |
| A novel ΔNp63-dependent immune mechanism improves prognosis of HPV-related head and neck cancer. | Front Immunol | 2023 | 38022675 | PubTator, text mining | PubMed |
| COPI vesicle formation and N-myristoylation are targetable vulnerabilities of senescent cells. | Nat Cell Biol | 2023 | 38012402 | PubTator, text mining | PubMed |
| Label-free quantitative proteomics analysis for type 2 diabetes mellitus early diagnostic marker discovery using data-independent acquisition mass spectrometry (DIA-MS). | Sci Rep | 2023 | 38012280 | PubTator, text mining | PubMed |
| Comparative Analysis of Alpha and Beta HPV E6 Oncoproteins: Insights into Functional Distinctions and Divergent Mechanisms of Pathogenesis. | Viruses | 2023 | 38005929 | PubTator, text mining | PubMed |
| Navigating the Gene Co-Expression Network and Drug Repurposing Opportunities for Brain Disorders Associated with Neurocognitive Impairment. | Brain Sci | 2023 | 38002524 | PubTator, text mining | PubMed |
| Relationship between the Ubiquitin-Proteasome System and Autophagy in Colorectal Cancer Tissue. | Biomedicines | 2023 | 38002011 | PubTator, text mining | PubMed |
| DEK oncoprotein participates in heterochromatin replication via SUMO-dependent nuclear bodies. | J Cell Sci | 2023 | 37997922 | PubTator, text mining | PubMed |
| APOL1-G2 accelerates nephrocyte cell death by inhibiting the autophagy pathway. | Dis Model Mech | 2023 | 37969018 | PubTator, text mining | PubMed |
| Identification and validation of autophagy-related genes in primary open-angle glaucoma. | BMC Med Genomics | 2023 | 37968618 | PubTator, text mining | PubMed |
| Interactome profiling of Crimean-Congo hemorrhagic fever virus glycoproteins. | Nat Commun | 2023 | 37963884 | PubTator, text mining | PubMed |
| Organ-Specificity of Breast Cancer Metastasis. | Int J Mol Sci | 2023 | 37958607 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis and Experimental Validation of SOX4 as a Potential Diagnosis, Prognosis, and Immunotherapy Biomarker. | Cancers (Basel) | 2023 | 37958409 | PubTator, text mining | PubMed |
| RNF14-dependent atypical ubiquitylation promotes translation-coupled resolution of RNA-protein crosslinks. | Mol Cell | 2023 | 37951216 | PubTator, text mining | PubMed |
| Quantitative transcriptomic and proteomic analysis reveals corosolic acid inhibiting bladder cancer via suppressing cell cycle and inducing mitophagy in vitro and in vivo. | Toxicol Appl Pharmacol | 2023 | 37939859 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7314/papers?page=5